LOAMS
Lombard Odier Asset Management (Switzerland)’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-54,786
| Closed | -$2.48M | – | 203 |
|
|
2023
Q1 | $2.48M | Sell |
54,786
-28,628
| -34% | -$1.29M | 0.22% | 111 |
|
|
2022
Q4 | $3.39M | Buy |
83,414
+24,239
| +41% | +$985K | 0.27% | 80 |
|
|
2022
Q3 | $3.87M | Sell |
59,175
-4,394
| -7% | -$287K | 0.33% | 70 |
|
|
2022
Q2 | $3.86M | Sell |
63,569
-127,116
| -67% | -$7.72M | 0.33% | 72 |
|
|
2022
Q1 | $12M | Buy |
190,685
+12,916
| +7% | +$811K | 0.94% | 41 |
|
|
2021
Q4 | $13.5M | Buy |
+177,769
| New | +$13.5M | 0.86% | 44 |
|